Your Gut Bacteria Might Be Your Best Defense Against Flu Complications

A specific type of gut bacteria called segmented filamentous bacteria (SFB) can provide remarkable protection against deadly secondary bacterial infections that commonly follow influenza, according to groundbreaking research from Georgia State University. The study, published in Science Immunology, found that mice with SFB in their intestines were significantly better protected against lethal respiratory infections caused by common bacteria like Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus after contracting influenza A virus.

How Does Gut Bacteria Protect Your Lungs?

The protective mechanism works through specialized immune cells in your lungs called alveolar macrophages. These cells normally act as your lungs' first line of defense against bacterial invaders, but they become severely weakened after a flu infection. What researchers discovered is that SFB bacteria, which live exclusively on the outer surface of your intestine, can actually reprogram these lung immune cells to resist flu-induced damage.

"The intestine is normally colonized by thousands of different bacterial species but yet, incredibly, adding one more completely changes the way that lung macrophages respond to pathogens," said lead author Vu Ngo, a research assistant professor in the Institute for Biomedical Sciences at Georgia State.

Tips for Protecting Yourself From Flu Complications Using Gut Bacteria

This finding could explain why some people survive severe flu outbreaks while others don't. Much of the death and serious illness caused by influenza pandemics actually results from secondary bacterial infections rather than the flu virus itself. The research suggests that your individual gut microbiome composition may be a crucial factor in determining whether you'll survive such infections.

The study examined three major respiratory bacterial pathogens that commonly cause life-threatening complications after flu infections:

• Streptococcus pneumoniae: A leading cause of bacterial pneumonia that can develop after viral respiratory infections
• Haemophilus influenzae: Despite its name, this bacteria (not the flu virus) causes severe respiratory tract infections
• Staphylococcus aureus: A dangerous bacteria that can cause pneumonia and other serious infections in flu-weakened patients

What This Means for Future Treatments

The research team is optimistic about translating these findings into new treatments. The discovery that intestinal bacteria can epigenetically reprogram lung immune cells opens up entirely new possibilities for preventing and treating respiratory infections. This epigenetic reprogramming means the bacteria actually change how genes are expressed in the lung cells without altering the DNA itself.

"We're very hopeful that we'll soon be able to harness the mechanism by which SFB reprograms alveolar macrophages, yielding novel pharmacologic approaches to mitigate the severity of a broad assortment of respiratory infections," added senior author Andrew T. Gewirtz of the Institute for Biomedical Sciences.

The study was funded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), highlighting the significant potential researchers see in this gut-lung connection. While this research was conducted in mice, it provides crucial insights into how our microbiome might influence our ability to fight off serious respiratory infections.